Dupilumab, an IgG4 Monoclonal Antibody, for Eosinophilic Esophagitis: Revising the Treatment Paradigm

Afrin Kamal, MD, MS and Editor-in-Chief Philip Schoenfeld, MD, MSEd, MScEpi discuss “Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis,” by Dellon ES, Rothenber MH, Collins I, et al. N Engl J Med [2022; 387: 2317-30].